Interleukin 6 (IL-6) is a typical pleiotropic cytokine that modulates a variety of physiological events in vertebrates, including cell proliferation, differentiation, survival, and apoptosis, among other functions. IL-6 plays roles in the immune, the endocrine, the nervous, and the hematopoietic systems, in bone metabolism, regulation of blood pressure and inflammation. IL-6 exerts its effects on different tissues and organ systems. Many cell types are reported to produce IL-6: T cells, B cells, polymorphonuclear cells, eosinophils, monocyte/macrophages, mast cells, dendritic cells, chondrocytes, osteoblasts, endothelial cells, skeletal and smooth muscle cells, islet cells, thyroid cells, fibroblasts, mesangial cells, keratinocytes, microglial cells, astrocytes, oligodendrocytes, adipose tissue and certain tumor cells. In this article we review the participation of the IL-6 in the neuroimmunoendocrine network that includes all interactions across species, sexes, cells, and types of responses. Additionally, we discuss the information that is available so far about the production of IL-6 by the neural cell populations, the role that this cytokine plays at the local level in the modulation of some physiological neural actions, as well as its participation in the development and progression of neuroinflammation and the neurodegenerative process.
Considering the multiple functions that IL-6 plays as an endocrine and neural regulator, the specific targeting of the IL-6 pathway can be a promising new approach for the treatment and prevention of neurodegenerative disorders in humans. Furthermore, blocking the effect of IL-6 may improve the autoinflammatory process both systemically and locally.
AgarwalVR, BulunSE, LeitchMA. R.I.L.Y.N, RohrichR, SimpsonER. Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients. The Journal of Clinical Endocrinology & Metabolism. 1996;81(11):3843–9.
2.
AkiraS, KishimotoT.Role of interleukin-6 in macrophage function. Current Opinion in Hematology. 1996;3(1):87–93.
3.
AliC, NicoleO, DocagneF, LesneS, MacKenzieET, NouvelotA, VivienD.Ischemia-induced interleukin-6 as a potential endogenous neuroprotective cytokine against NMDA receptor-mediated excitoxicity in the brain. Journal of Cerebral Blood Flow & Metabolism. 2000;20(6):956–66.
4.
AngelopoulosP, AgouridakiH, VaiopoulosH, SiskouE, DoutsouK, CostaV, BaloyiannisSI. Cytokines in Alzheimer's disease and vascular dementia. International Journal of Neuroscience. 2008;118(12):1659–72.
5.
ArnoldMC, PapanicolaouDA, O'gradyJA, LotsikasA, DaleJK, StrausSE, GrafmanJ.Using an interleukin-6 challenge to evaluate neuropsychological performance in chronic fatigue syndrome. Psychological Medicine. 2002;32(6):1075–89.
6.
Ataie-KachoieP, PourgholamiMH, RichardsonDR, MorrisDL. Gene of the month: Interleukin 6 (IL-6). Journal of Clinical Pathology. 2014;67(11):932–7.
7.
BatailleR, JourdanM, ZhangXG, KleinB.Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias. Journal of Clinical Investigation. 1989;84(6):2008.
8.
BengaA, ZorF, KorkmazA, MarinescuB, GorantlaV.The neurochemistry of peripheral nerve regeneration. Indian Journal of Plastic Surgery: Official Publication of the Association of Plastic Surgeons of India. 2017;50(1):5.
9.
BenvenisteEN. Cytokine actions in the central nervous system. Cytokine & Growth Factor Reviews. 1998;9(3):259–75.
10.
BesedovskyHO, Del ReyA.The cytokine-HPA axis feed-back circuit. Zeitschrift für Rheumatologie. 2000;59(8):II26–II30.
11.
BianchiM, FerrarioP, ClavennaA, PaneraiAE. Interleukin-6 affects scopolamine-induced amnesia, but not brain amino acid levels in mice. Neuroreport. 1997;8(7):1775–8.
12.
BuckinghamJC, LoxleyHD, ChristianHC, PhilipJG. Activation of the HPA axis by immune insults: Roles and interactions of cytokines, eicosanoids, and glucocorticoids. Pharmacology Biochemistry and Behavior. 1996;54(1):285–98.
13.
CacquevelM, LebeurrierN, ChéenneS, VivienD.Cytokines in neuroinflammation and Alzheimer's disease. Current Drug Targets. 2004;5(6):529–34.
14.
CampbellIL, AbrahamCR, MasliahE, KemperP, InglisJD, OldstoneMB, MuckeL.Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proceedings of the National Academy of Sciences. 1993;90(21):10061–5.
15.
CarpenterMK, CuiX, HuZY, JacksonJ, ShermanS, SeigerÅ, WahlbergLU. In vitro expansion of a multipotent population of human neural progenitor cells. Experimental Neurology. 1999;158(2):265–78.
16.
CarrDJ, CampbellIL. Transgenic expression of interleukin-6 in the central nervous system confers protection against acute herpes simplex virus type-1 infection. Journal of Neurovirology. 1999;5(5):449–57.
17.
ChaiZ, GattiS, ToniattiC, PoliV, BartfaiT.Interleukin (IL)-6 gene expression in the central nervous system is necessary for fever response to lipopolysaccharide or IL-1 beta: A study on IL-6-deficient mice. Journal of Experimental Medicine. 1996;183(1):311–6.
18.
ChenL, FristerA, WangS, LudwigA, BehrH, PippigS, KochS.Interaction of vascular smooth muscle cells and monocytes by soluble factors synergistically enhances IL-6 and MCP-1 production. American Journal of Physiology-Heart and Circulatory Physiology. 2009;296(4):H987–H996.
19.
ChibanteA, VazM, VargasFA. il-6 behaviour on acute pleural effusions after coronary artery bypass graft. Rev Port Pneumol. 2006;12: 29–30.
20.
ChomaratP, BanchereauJ, DavoustJ, PaluckaAK. IL-6 switches the differentiation of monocytes from dendritic cells to macrophages. Nature Immunology. 2000;1(6):510–4.
21.
ChoyE, Rose-JohnS.Interleukin-6 as a multifunctional regulator: Inflammation, immune response, and fibrosis. Journal of Scleroderma and Related Disorders. 2017;2(2_suppl):1–5.
22.
ChungIY, BenvenisteEN. Tumor necrosis factor-alpha production by astrocytes. Induction by lipopolysaccharide, IFN-gamma, and IL-1 beta. The Journal of Immunology. 1990;144(8):2999–3007.
23.
CojocaruIM, CojocaruM, MiuGAB.R.I.E.L.A, SapiraV.Study of interleukin-6 production in Alzheimer's disease. Rom J Intern Med. 2011;49(1):55–8.
24.
CornetA, BettelliE, OukkaM, CambourisC, Avellana-AdalidV, KosmatopoulosK, LiblauRS. Role of astrocytes in antigen presentation and naive T-cell activation. Journal of Neuroimmunology. 2000;106(1):69–77.
25.
CrichtonMB, NicholsJE, ZhaoY, BulunSE, SimpsonER. Expression of transcripts of interleukin-6 and related cytokines by human breast tumors, breast cancer cells, and adipose stromal cells. Molecular and Cellular Endocrinology. 1996;118(1):215–20.
26.
CudiciniC, LejeuneH, GomezE, BosmansE, BalletF, SaezJ, JégouB.Human Leydig cells and Sertoli cells are producers of interleukins-1 and-6. The Journal of Clinical Endocrinology & Metabolism. 1997;82(5):1426–33.
27.
CutoloM, SulliA, PizzorniC, CraviottoC, StraubRH. Hypothalamic-pituitary-adrenocortical and gonadal functions in rheumatoid arthritis. Annals of the New York Academy of Sciences. 2003;992(1):107–17.
28.
CutoloM, VillaggioB, FoppianiL, BriataM, SulliA, PizzorniC, GiustiM.The hypothalamic-pituitary-adrenal and gonadal axes in rheumatoid arthritis. Annals of the New York Academy of Sciences. 2000;917(1):835–43.
29.
CzlonkowskaA, CiesielskaA, GromadzkaG, Kurkowska-JastrzebskaI.Estrogen and cytokines production-the possible cause of gender differences in neurological diseases. Current Pharmaceutical Design. 2005;11(8):1017–30.
30.
De LaurentiisA, PiseraD, LasagaM, del Carmen DíazM, TheasS, DuvilanskiB, SeilicovichA.Effect of interleukin-6 and tumor necrosis factor-α on GABA release from mediobasal hypothalamus and posterior pituitary. Neuroimmunomodulation. 2000;7(2):77–83.
31.
DiehlS, RincónM.The two faces of IL-6 on Th1/Th2 differentiation. Molecular Immunology. 2002;39(9):531–6.
32.
DienzO, RinconM.The effects of IL-6 on CD4 T cell responses. Clinical Immunology. 2009;130(1):27–33.
33.
DinarelloCA, CannonJG, MancillaJ, BishaiI, LeesJ, CoceaniF.Interleukin-6 as an endogenous pyrogen: Induction of prostaglandin E 2 in brain but not in peripheral blood mononuclear cells. Brain Research. 1991;562(2):199–206.
34.
DongY, BenvenisteEN. Immune function of astrocytes. Glia. 2001;36(2):180–90.
35.
ElenkovIJ, WebsterEL, TorpyDJ, ChrousosGP. Stress, corticotropin-releasing hormone, glucocorticoids, and the immune/inflammatory response: Acute and chronic effects. Annals of the New York Academy of Sciences. 1999;876(1):1–13.
36.
EllingsgaardH, HauselmannI, SchulerB, HabibAM, BaggioLL, MeierDT, HansenAMK. Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells. Nature Medicine. 2011;17(11):1481–9.
37.
EngelhardtBRegulation of immune cell entry into the central nervous system. In Cell Communication in Nervous and Immune System. (259–280). Springer Berlin Heidelberg. 2006.
38.
ErtaM, QuintanaA, HidalgoJ.Interleukin-6, a major cytokine in the central nervous system. International Journal of Biological Sciences. 2012;8(9):1254.
39.
FelederC, RefojoD, JarryH, WuttkeW, MoguilevskyJA. Bacterial endotoxin inhibits LHRH secretion following the increased release of hypothalamic GABA levels. Neuroimmunomodulation. 1996;3(6):342–51.
FlattersSJ, FoxAJ, DickensonAH. Nerve injury alters the effects of interleukin-6 on nociceptive transmission in peripheral afferents. European Journal of Pharmacology. 2004;484(2):183–91.
42.
GiulianD, LiJ, LiX, GeorgeJ, RuteckiPA. The impact of microglia-derived cytokines upon gliosis in the CNS. Developmental Neuroscience. 1994;16(3-4):128–36.
43.
GodboutJP, JohnsonRW. Interleukin-6 in the aging brain. Journal of Neuroimmunology. 2004;147(1):141–4.
44.
GorospeWC, HughesFMJr, SpangeloBL. Interleukin- Effects on and production by rat granulosa cells in vitro. Endocrinology. 1992;130(3):1750–2.
45.
GrossmanCJ, RoselleGA. The interrelationship of the HPG-thymic axis and immune system regulation. Journal of Steroid Biochemistry. 1983;19(1):461–7.
46.
GrossmanRM, KruegerJ, YourishD, Granelli-PipernoA, MurphyDP, MayLT, GottliebAB. Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. Proceedings of the National Academy of Sciences. 1989;86(16):6367–71.
47.
GrünblattE, MandelS, YoudimMB. MPTP and 6-hydroxydopamine-induced neurodegeneration as models for Parkinson's disease: Neuroprotective strategies. Journal of Neurology. 2000;247(2):II95–II102.
48.
HakkoumD, StoppiniL, MullerD.Interleukin-6 promotes sprouting and functional recovery in lesioned organotypic hippocampal slice cultures. Journal of Neurochemistry. 2007;100(3):747–57.
49.
HeinrichPC, BehrmannI, SergeHAAN, HermannsHM, Müller-NewenG, SchaperF.Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochemical Journal. 2003;374(1):1–20.
50.
HiranoT, MatsudaT, TurnerM, MiyasakaN, BuchanG, TangB, KishimotoT.Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis. European Journal of Immunology. 1988;18(11):1797–802.
51.
HoriiY, MuraguchiA, IwanoM, MatsudaT, HirayamaT, YamadaH, OhmotoY.Involvement of IL-6 in mesangial proliferative glomerulonephritis. The Journal of Immunology. 1989;143(12):3949–55.
52.
HoozemansJJM, VeerhuisR, JanssenI, RozemullerAJM, EikelenboomP.Interleukin-1β induced cyclooxygenase 2 expression and prostaglandin E2 secretion by human neuroblastoma cells: Implications for Alzheimer's disease. Experimental Gerontology. 2001;36(3):559–70.
53.
HuS, MartellaA, AndersonWR, ChaoCC. Role of cytokines in lipopolysaccharide-induced functional and structural abnormalities of astrocytes. Glia. 1994;10(3):227–34.
54.
HsiaoEY, PattersonPH. Activation of the maternal immune system induces endocrine changes in the placenta via IL-6. Brain, Behavior, and Immunity. 2011;25(4):604–15.
55.
IshiguroH, KishimotoT, FuruyaM, NagaiY, WaT, IshikuraH.Tumor-derived interleukin (IL)-6 induced anti-tumor effect in immune-compromised hosts. Cancer Immunology, Immunotherapy. 2005;54(12):1191–9.
56.
IslamO, GongX, Rose-JohnS, HeeseK.Interleukin-6 and neural stem cells: More than gliogenesis. Molecular Biology of the Cell. 2009;20(1):188–99.
57.
JehnCF, FlathB, StruxA, KrebsM, PossingerK, PezzuttoA, LüftnerD.Influence of age, performance status, cancer activity, and IL-6 on anxiety and depression in patients with metastatic breast cancer. Breast Cancer Research and Treatment. 2012;136(3):789–94.
58.
JiC, ChenX, GaoC, JiaoL, WangJ, XuG, ZhaoY.IL-6 induces lipolysis and mitochondrial dysfunction, but does not affect insulin-mediated glucose transport in 3T3-L1 adipocytes. Journal of Bioenergetics and Biomembranes. 2011;43(4):367.
59.
JilkaRL, HangocG, GirasoleG, PasseriG, WilliamsDC, AbramsJS, ManolagasSC. Increased osteoclast development after estrogen loss: Mediation by interleukin-6. Science. 1992;257(5066):88–91.
60.
KarnowskiA, ChevrierS, BelzGT, MountA, EmslieD, D'CostaK. B and T cells collaborate in antiviral responses via IL-6, IL-21, and transcriptional activator and coactivator, Oct2 and OBF-1. J Exp Med. 2012;209(11):2049–64.
61.
KawanoM, HiranoT, MatsudaT, TagaT, HoriiY, IwatoK, KuramotoA.Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature. 1988;332(6159):83–5.
62.
KellerC, SteensbergA, HansenAK, FischerCP, PlomgaardP, PedersenBK. Effect of exercise, training, and glycogen availability on IL-6 receptor expression in human skeletal muscle. Journal of Applied Physiology. 2005;99(6):2075–9.
63.
KilpatrickTJ, ButzkuevenH, EmeryB, MarriottM, TaylorBV, TubridyN.Neuroglial responses to CNS injury: Prospects for novel therapeutics. Expert Review of Neurotherapeutics. 2004;4(5):869–78.
64.
KimS, ÖstörAJ, NisarMK. Interleukin-6 and cytochrome-P450, reason for concern? Rheumatology International. 2012;32(9):2601–4.
65.
KomatsuN, OkamotoK, SawaS, NakashimaT, Oh-HoraM, KodamaT. Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis. Nat Med. 2014;20(1):62–8.
66.
KozakW, KlugerMJ, SoszynskiD, ConnCA, RudolphK, LeonLR, ZhengH.IL-6 and IL-1β in Fever: Studies Using Cytokine-Deficient (Knockout) Mice. Annals of the New York Academy of Sciences. 1998;856(1):33–47.
67.
KozoraE, LaudenslagerM, LemieuxA, WestSG. Inflammatory and hormonal measures predict neuropsychological functioning in systemic lupus erythematosus and rheumatoid arthritis patients. Journal of the International Neuropsychological Society. 2001;7(6):745–54.
68.
LehtimäkiKA, PeltolaJ, KoskikallioE, KeränenT, HonkaniemiJ.Expression of cytokines and cytokine receptors in the rat brain after kainic acid-induced seizures. Molecular Brain Research. 2003;110(2):253–60.
69.
LeibingerM, MüllerA, GobrechtP, DiekmannH, AndreadakiA, FischerD.Interleukin-6 contributes to CNS axon regeneration upon inflammatory stimulation. Cell Death & Disease. 2013;4(4):e609.
70.
LiuQS, XuQ, ArcuinoG, KangJ, NedergaardM.Astrocyte-mediated activation of neuronal kainate receptors. Proceedings of the National Academy of Sciences of the United States of America. 2004;101(9):3172–7.
71.
LiuY, HoRCM, MakA.Interleukin (IL)-6, tumour necrosis factor alpha (TNF-α) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: A meta-analysis and meta-regression. Journal of Affective Disorders. 2012;139(3):230–9.
72.
LysonK, McCannSM. The effect of interleukin-6 on pituitary hormone release in vivo and in vitro. Neuroendocrinology. 1991;54(3):262–6.
73.
ManolagasSC. The role of il-6 type cytokines and their receptors in bone. Ann N Y Acad Sci. 1998;840: 194–204.
74.
MarslandAL, GianarosPJ, AbramowitchSM, ManuckSB, HaririAR. Interleukin-6 covaries inversely with hippocampal grey matter volume in middle-aged adults. Biological Psychiatry. 2008;64(6):484–90.
75.
MilesSA, RezaiAR, Salazar-GonzalezJF, Vander MeydenM, StevensRH, LoganDM, KishimotoT.AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6. Proceedings of the National Academy of Sciences. 1990;87(11):4068–72.
76.
MillerDB, O'CallaghanJP. Depression, cytokines, and glial function. Metabolism. 2005;54(5):33–8.
77.
MinagarA, ShapshakP, FujimuraR, OwnbyR, HeyesM, EisdorferC.The role of macrophage/microglia and astrocytes in the pathogenesis of three neurologic disorders: HIV-associated dementia, Alzheimer disease, and multiple sclerosis. Journal of the Neurological Sciences. 2002;202(1):13–23.
78.
MitaniH, KatayamaN, ArakiH, OhishiK, KobayashiK, SuzukiH, ShikuH.Activity of interleukin 6 in the differentiation of monocytes to macrophages and dendritic cells. British Journal of Haematology. 2000;109(2):288–95.
79.
MockBA, NordanRP, JusticeMJ, KozakC, JenkinsNA, CopelandNG, RudikoffS.The murine Il-6 gene maps to the proximal region of chromosome 5. The Journal of Immunology. 1989;142(4):1372–6.
80.
MorrowLE, McClellanJL, ConnCA, KlugerMJ. Glucocorticoids alter fever and IL-6 responses to psychological stress and to lipopolysaccharide. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 1993;264(5):R1010–R1016.
81.
NakajimaK, Martinez-MazaO, HiranoT, BreenEC, NishanianPG, Salazar-GonzalezJF, KishimotoT.Induction of IL-6 (B cell stimulatory factor-2/IFN-beta 2) production by HIV. The Journal of Immunology. 1989;142(2):531–6.
82.
NaitoY, TakagiT, UchiyamaK, KurodaM, KokuraS, IchikawaH, YoshidaN.Reduced intestinal inflammation induced by dextran sodium sulfate in interleukin-6-deficient mice. International Journal of Molecular Medicine. 2004;14(2):191–6.
83.
NelsonTE, CampbellIL, GruolDL. Altered physiology of Purkinje neurons in cerebellar slices from transgenic mice with chronic central nervous system expression of interleukin-6. Neuroscience. 1999;89(1):127–36.
84.
NelsonTE, UrCL, GruolDL. Chronic interleukin-6 exposure alters electrophysiological properties and calcium signaling in developing cerebellar purkinje neurons in culture. Journal of Neurophysiology. 2002;88(1):475–86.
85.
NockherWA, RenzH.Neurotrophins in clinical diagnostics: Pathophysiology and laboratory investigation. Clinica Chimica Acta. 2005;352(1):49–74.
86.
NodaM, TakedaK, SugimotoH, HosoiT, TakechiK, HaraT, KonnoK.Purification and characterization of human fibroblast derived differentiation inducing factor for human monoblastic leukemia cells identical to interleukin-6. Anticancer Research. 1991;11(2):961–8.
87.
Owen-AshleyNT, TurnerM, HahnTP, WingfieldJC. Hormonal, behavioral, and thermoregulatory responses to bacterial lipopolysaccharide in captive and free-living white-crowned sparrows (Zonotrichia leucophrys gambelii). Hormones and Behavior. 2006;49(1):15–29.
88.
ParadowskiB, CelczyńskaD, DoboszT, NogaL.Polymorphism 174 G/C of interleukin 6 gene in Alzheimer's disease–preliminary report. Neurologia i Neurochirurgia Polska. 2008;42(4):312–5.
89.
ParkYM, KimCW. The effects of substance P and vasoactive intestinal peptide on interleukin-6 synthesis in cultured human keratinocytes. Journal of Dermatological Science. 1999;22(1):17–23.
90.
PedersenBK. Muscular interleukin-6 and its role as an energy sensor. Medicine and Science in Sports and Exercise. 2012;44(3):392–6.
91.
PoliG, BresslerP, KinterA, DuhE, TimmerWC, RabsonA, JustementJS, StanleyS, FauciAS. Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and post-transcriptional mechanisms. J Exp Med. 1990;172: 151–8.
92.
PoliV, BalenaR, FattoriE, MarkatosA, YamamotoM, TanakaH, CostantiniF.Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. The EMBO Journal. 1994;13(5):1189.
93.
ReyesTM, FabryZ, CoeCL. Brain endothelial cell production of a neuroprotective cytokine, interleukin-6, in response to noxious stimuli. Brain Research. 1999;851(1):215–20.
94.
RizzoSS, NealSJ, HughesZA, BeynaM, Rosenzweig-LipsonS, MossSJ, BrandonNJ. Evidence for sustained elevation of IL-6 in the CNS as a key contributor of depressive-like phenotypes. Translational Psychiatry. 2012;2(12):e199.
95.
RongY, BaudryM.Seizure Activity Results in a Rapid Induction of Nuclear Factor-κB in Adult but Not Juvenile Rat Limbic Structures. Journal of Neurochemistry. 1996;67(2):662–8.
96.
RönnbäckL, HanssonE.On the potential role of glutamate transport in mental fatigue. Journal of Neuroinflammation. 2004;1(1):22.
97.
RummelC, InoueW, SachotC, PooleS, HübschleT, LuheshiGN. Selective contribution of interleukin-6 and leptin to brain inflammatory signals induced by systemic LPS injection in mice. Journal of Comparative Neurology. 2008;511(3):373–95.
98.
SamlandH, Huitron-ResendizS, MasliahE, CriadoJ, HenriksenSJ, CampbellIL. Profound increase in sensitivity to glutamatergic-but not cholinergic agonist-induced seizures in transgenic mice with astrocyte production of IL-6. Journal of Neuroscience Research. 2003;73(2):176–87.
99.
SatohJI, KurodaY.Cytokines and neurotrophic factors fail to affect Nogo-A mRNA expression in differentiated human neurones: Implications for inflammation-related axonal regeneration in the central nervous system. Neuropathology and Applied Neurobiology. 2002;28(2):95–106.
100.
SchwielerL, LarssonMK, SkoghE, KegelME, OrhanF, AbdelmoatyS, DahlML. Increased levels of IL-6 in the cerebrospinal fluid of patients with chronic schizophrenia— significance for activation of the kynurenine pathway. Journal of Psychiatry & Neuroscience: JPN. 2015;40(2):126.
101.
Schöbitz B ReulJM, HolsboerF.The role of the hypothalamic-pituitary-adrenocortical system during inflammatory conditions. Critical Reviews in Neurobiology. 1994;8(4):263–91.
102.
SehgalPB, ZilbersteinA, RuggieriRM, MayLT, Ferguson-SmithA, SlateDL, RuddleFH. Human chromosome 7 carries the beta 2 interferon gene. Proceedings of the National Academy of Sciences. 1986;83(14):5219–22.
103.
SehgalPB. Interleukin- Molecular pathophysiology. Journal of Investigative Dermatology. 1990;94.
104.
Shapira-LichterI, BeilinB, OfekK, BesslerH, GrubergerM, ShavitY, SoreqH.Cytokines and cholinergic signals co-modulate surgical stress-induced changes in mood and memory. Brain, Behavior, and Immunity. 2008;22(3):388–98.
105.
SnickJV, CayphasS, SzikoraJP, RenauldJC, RoostEV, BoonT, SirnpsonRJ. cDNA cloning of murine interleukin-HP Homology with human interleukin 6. European Journal of Immunology. 1988;18(2):193–7.
106.
SomersW, StahlM, SeehraJS. 1.9 a crystal structure of interleukin Implications for a novel mode of receptor dimerization and signaling. EMBO J. 1997;16: 989–97.
107.
SontheimerH.Astrocytes, as well as neurons, express a diversity of ion channels. Canadian Journal of Physiology and Pharmacology. 1992;70(1s):S223–S238.
108.
SpoorenA, KolmusK, LaureysG, ClinckersR, DeKeyser J, HaegemanG, GerloS.Interleukin-6, a mental cytokine. Brain Research Reviews. 2011;67(1):157–83.
109.
SteensbergA, FebbraioMA, OsadaT, SchjerlingP, HallG, SaltinB, PedersenBK. Interleukin-6 production in contracting human skeletal muscle is influenced by pre-exercise muscle glycogen content. The Journal of Physiology. 2001;537(2):633–9.
110.
Sundgren-AnderssonAK, ÖstlundP, BartfaiT.IL-6 is essential in TNF-α-induced fever. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 1998;275(6):R2028–R2034.
TagaT, FukudaS.Role of IL-6 in the neural stem cell differentiation. Clinical Reviews in Allergy & Immunology. 2005;28(3):249–56.
113.
TanabeO, AkiraS, KamiyaT, WongGG, HiranoT, KishimotoT.Genomic structure of the murine IL-6 gene. High degree conservation of potential regulatory sequences between mouse and human. The Journal of Immunology. 1988;141(11):3875–81.
114.
TanakaT, NarazakiM, KishimotoT.IL-6 in inflammation, immunity, and disease. Cold Spring Harbor Perspectives in Biology. 2014;6(10):a016295.
115.
TancrediV, D'AntuonoM, CafèC, GiovedìS, BuèMC, D'ArcangeloG, BenfenatiF.The inhibitory effects of interleukin-6 on synaptic plasticity in the rat hippocampus are associated with an inhibition of mitogen-activated protein kinase ERK. Journal of Neurochemistry. 2000;75(2):634–43.
116.
TarkowskiE, LiljerothAM, MinthonL, TarkowskiA, WallinA, BlennowK.Cerebral pattern of pro-and anti-inflammatory cytokines in dementias. Brain Research Bulletin. 2003;61(3):255–60.
117.
Van WagonerNJ, BenvenisteEN. Interleukin-6 expression and regulation in astrocytes. Journal of Neuroimmunology. 1999;100(1):124–39.
118.
WaageA, BrandtzaegP, HalstensenA, KierulfP, EspevikT.The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. J Exp Med. 1989;169: 333–8.
119.
WagnerJA. Is IL-6 both a cytokine and a neurotrophic factor? Journal of Experimental Medicine. 1996;183(6):2417–9.
120.
WangWY, TanMS, YuJT, TanL.Role of pro-inflammatory cytokines released from microglia in Alzheimer's disease. Annals of Translational Medicine. 2015;3(10).
121.
WeiH, ZouH, SheikhAM, MalikM, DobkinC, BrownWT, LiX.IL-6 is increased in the cerebellum of autistic brain and alters neural cell adhesion, migration and synaptic formation. Journal of Neuroinflammation. 2011;8(1):52.
122.
WeiH, ChadmanKK, McCloskeyDP, SheikhAM, MalikM, BrownWT, LiX.Brain IL-6 elevation causes neuronal circuitry imbalances and mediates autism-like behaviors. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease. 2012;1822(6):831–42.
123.
WilderRL. Hormones and autoimmunity: Animal models of arthritis. Bailliere's Clinical Rheumatology. 1996;10(2):259–71.
124.
YanHQ, BanosMA, HerregodtsP, HoogheR, Hooghe-PetersEL. Expression of interleukin (IL)-1β, IL-6 and their respective receptors in the normal rat brain and after injury. European Journal of Immunology. 1992;22(11):2963–71.
125.
YangP, WenH, OuS, CuiJ, FanD.IL-6 promotes regeneration and functional recovery after cortical spinal tract injury by reactivating intrinsic growth program of neurons and enhancing synapse formation. Experimental Neurology. 2012;236(1):19–27.
126.
YamaguchiM, MatsuzakiN, HirotaK, MiyakeA, TanizawaO.Interleukin 6 possibly induced by interleukin 1β in the pituitary gland stimulates the release of gonadotropins and prolactin. Acta Endocrinologica. 1990;122(2):201–5.
127.
YasukawaK, HiranoT, WatanabeY, MurataniK, MatsudaT, NakaiS, KishimotoT.Structure and expression of human B cell stimulatory factor-2 (BSF-2/IL-6) gene. The EMBO Journal. 1987;6(10):2939.
128.
YirmiyaR, GoshenI.Immune modulation of learning, memory, neural plasticity and neurogenesis. Brain, Behavior, and Immunity. 2011;25(2):181–213.
129.
YoshizakiK, MatsudaT, NishimotoN, KuritaniT, TaehoL, AozasaK, KomoriT.Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman9s disease. Blood. 1989;74(4):1360–7.
130.
ZampronioAR, HoadleyME, LuheshiG, RothwellNJ, DeSouza GE, HopkinsSJ. Interleukin (IL)-6 release and fever induced by a pre-formed pyrogenic factor (PFPF) derived from LPS-stimulated macrophages. European Cytokine Network. 2000;11(4):589–96.
131.
ZilbersteinA, RuggieriR, KornJH, RevelM.Structure and expression of cDNA and genes for human interferon-beta-2, a distinct species inducible by growth-stimulatory cytokines. The EMBO Journal. 1986;5(10):2529.
